AMRN
Amarin is a global pharmaceutical company focused on cardiovascular health, pursuing therapies to cost-effectively address cardiovascular disease and improve patient outcomes worldwide. The company emphasizes scientific breakthroughs and has developed products and pipeline programs aimed at lipid management and cardiovascular protection. It operates with a global footprint, providing information and updates through investor relations, science and health channels, and patient-focused resources. Amarin brands include VASCEPA and REDUCE-IT-related initiatives, reflecting its commitment to advancing cardiovascular care globally.
No recent deals for this company.